Biocompatible polymeric nanocomplexes as an intracellular stimuli-sensitive prodrug for type-2 diabe

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:qyyqyy202
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Combination therapy is usually considered as a promising strategy owing to its advantages such as reduced doses, minimized side effects and improved therapeutic efficiency in a variety of diseases including diabetes.
其他文献
Systemically administered anticancer treatments were greatly limited by extensive side effects mainly due to nonspecific distributions in vivo and multidrug resistance in various tumors.A phospholipid
会议
Nanobubbles represent a promising nano-sized ultrasonic contrast agent for tumor targeting ultrasonic imaging.Novel amphiphilic PAEEP-PLLA copolymer was synthesized by ring-opening polymerization reac
会议
Based on the excellent characteristics of chitosan (CS) and methoxy poly(ethylene glycol) (mPEG), a series of methoxy poly(ethylene glycol)-grafted-chitosan (mPEG-g-CS) were synthesized and utilized i
Retinal diseases are the primary causes for visual impairment.One of the greatest challenges for retinal diseases therapy is low efficiency of topical administration.The purpose of this study is to pr
Although collagen peptide has been used in therapeutic applications for a long time, the absorption mechanism is not well understood.
会议
Traditionally, synergistic phototermal therapy (PTT) and photodynamic therapy (PDT) usually depended on two near-infrared (NIR) lasers in different wavelengths to induce PTT and PDT effect,respectivel
Polymeric nanoparticle coated with intact red blood cell (RBC) membrane has emerged as biomimetic toxin nanosponges that absorb membrane-damaging toxins and divert them away from their cellular target
Vascular dementia (VaD) is regarded as the second most frequent type of dementia world-wide following Alzheimers disease.Treatment of vascular dementia remains a challenge in clinical practice mostly
OBJECTIVES: This review mainly summarized the progress in research of crossing blood brain barrier by nano-pharmaceutics, includes the hotspots, difficulty andtrends of research.METHODS:Mainly review
The blood brain barrier (BBB) represents the biggest challenge for therapeutic drugs to enter the brain.In our study, we selected chlorambucil (CHL), an alkylating agent, as the model therapeutic agen
会议